Posts filtered by tags: National blog main[x]


NorthStar Secures $75M+ as Medical Radioisotope Competition Revs Up

U.S. technology startups continue to pull in heaps of cash to try and stave off shortages of a crucial medical radioisotope.NorthStar Medical Technologies said this week it closed a deal to receive up to $100 million in secured debt financing from funds managed by Oberland Capital Management. Beloit, WI-based NorthStar said it received $75 million up front, and the company has the option to draw $25 million more by the end of 2020.NorthStar said it will use the funding to expand its capacity fo...
Tags: National blog main, Wisconsin, Wisconsin blog main, Wisconsin top stories, Cleantech, Coquí Pharma, Deals, Deerfield, Deerfield Management, Diagnostics, FDA, Greg Piefer, Healthcare, Healthtech, Imaging, Isotope

CI Security Raises $9.6M to Help Customers Manage Cyber Threats

CI Security, a startup that provides its customers with cybersecurity software and expertise in detecting and responding to digital intrusions and threats, announced Monday it has raised $9.6 million in new funding. Seattle-based CI Security, which was previously known as Critical Informatics, says it plans to use some of the new cash to continue developing its products and services.The only investor CI Security named in a news release announcing the Series B round was East Seattle Partners, wh...
Tags: Amazon, Deals, Startups, Internet Of Things, Microsoft, Government, Trends, Tech, Cybersecurity, Data Breach, Vc, Hacking, Hacks, Healthcare, Aws, Manufacturing

MagniX, Eviation Partner to Develop Electric Plane For Short Flights

MagniX and Eviation Aircraft, two businesses working to get the nascent electric airplane industry off the ground, announced a partnership Monday under which Eviation will outfit one of the planes it’s developing with an electric propulsion system made by MagniX.The partnership, which was fittingly unveiled on Earth Day, could ultimately lead to some passengers taking short-distance flights aboard planes powered by electricity, rather than jet fuel. Aircraft with electric motors would add less ...
Tags: Deals, Startups, Planes, Israel, Trends, Flight, Electric Vehicles, Aircraft, Airplanes, Aviation, Seattle, National blog main, Seattle blog main, Seattle top stories, Xperience, Harbour Air

Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More

Persistence and perseverance were the themes of two of our top stories this week.First there’s the story of Nationwide Children’s Hospital. The Columbus, Ohio, hospital chose to invest in gene therapy when the field was in its darkest days. After some ups and downs, the team it put in place helped advance some of the most promising gene therapies currently in human testing—and put Nationwide in the national spotlight as one of those treatments nears FDA approval.Then there’s Suzanne Ildstad. A ...
Tags: Deals, Startups, Usa, Trends, Vc, Fda, National, University of Pennsylvania, Novartis, Allergan, Biotech, Crispr, Life Sciences, Clinical Trials, Amgen, Gilead Sciences

TerraClear Raises $4.7M for Machine Designed to Pick Rocks from Soil

TerraClear, a Bellevue, WA-based startup launched two years ago with the vision of using software and high-tech machinery to automatically remove rocks from soil farmers plan to grow crops in, has raised nearly $4.7 million to support commercialization efforts, according to a regulatory filing.Three investors participated in the equity funding round, the filing shows. TerraClear previously raised more than $5.5 million from investors in a financing disclosed to regulators last July.Multiple mem...
Tags: Deals, Startups, Trends, Vc, Farming, Agriculture, Gps, Seattle, Roomba, National blog main, Seattle blog main, Seattle top stories, Bellevue WA, Smartsheet, AgtechFood, Airobotics

Hookipa’s IPO Raises $84M for Drugs to Reprogram the Immune System

Hookipa Pharma has raised $84 million in an initial public offering that will fund development of experimental treatments developed to reprogram the immune system to treat infectious diseases and cancer.But Hookipa (NASDAQ: HOOK) had to downsize its IPO, offering only 6 million shares at $14 apiece. That was the low end of its targeted $14 to $16 range. Hookipa had initially planned to sell 6.7 million shares. In the first day of trading Thursday, Hookipa shares hovered around the IPO price.Hoo...
Tags: Deals, New York, Ipo, Hiv, Trends, Investing, Prostate Cancer, Immunotherapy, Biotech, Life Sciences, Clinical Trials, Gilead Sciences, National blog main, San Francisco blog main, Hookipa, Cancer Immunotherapy

Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise

Bardy Diagnostics, a Seattle-based business developing a cardiac monitor and arrhythmia detection device, announced this week it has raised $35.5 million from investors to hire additional salespeople and fund continued product development.Bardy’s flagship device is an hourglass-shaped patch that Bardy says is designed to be placed on the center of the patient’s chest, over the heart, to diagnose arrhythmia, an irregular heartbeat condition. Patients can wear the patch, which Bardy calls the Car...
Tags: Deals, Startups, Trends, Vc, Healthcare, Heart Health, Heart, Biotech, Seattle, Life Sciences, Medical Devices, Cam, Boston Scientific, Ascension Ventures, Welch Allyn, Bardy

It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help

Arrakis Therapeutics has been scouting elusive pharmaceutical quarry: small molecules able to “drug” RNA, the molecular messengers that carry the genetic instructions for proteins. Most drugs in use today act on proteins. But CEO Michael Gilman says targeting the genetic blueprints could prevent RNA from translating those instructions into disease-causing proteins in the first place.Waltham, MA-based Arrakis is now ramping up to turn its discoveries into potential drugs and it has $75 million t...
Tags: Deals, Boston, Cancer, Trends, Investing, Vc, Venture Capital, Novartis, Biotech, Life Sciences, Celgene, Roche, Gilman, Alexandria Venture Investments, Osage University Partners, University of North Carolina at Chapel Hill

$100M For Talaris Gives Surgeon a Shot to Reinvent Organ Transplants

When Novartis dissolved its gene and cell therapy unit a few years ago, a bunch of projects the Swiss pharma giant had incubated were tossed aside. One of them was the work of surgeon Suzanne Ildstad, who has spent decades trying to develop a new way to improve the health outcomes of patients who need organ transplants.That work has just been salvaged. If it plays out as Ildstad hopes, her company might not only help transform treatment for kidney failure patients—but possibly, for people suffe...
Tags: Deals, Startups, Boston, Trends, Vc, National Institutes of Health, Novartis, Stem Cell, Stanford University, Life Sciences, Blackstone Group, Louisville Ky, National blog main, New York blog main, New York top stories, Seattle blog main

6sense Raises $27M to Uncover Hidden Interests of B2B Buyers

Let’s say you’re wondering whether another software provider could do a better job for your business than the one you already use. You start a web search on its competitors. Suddenly, you get a friendly message from your current software provider, asking how things are going.Was it a sixth sense? Nope, as you can probably guess by now. It’s technology.Companies such as 6sense are using advanced data analytics and artificial intelligence software to help their customers find early signals of int...
Tags: Deals, Startups, Mobile, Internet, Entrepreneurship, Funding, San Francisco, Trends, Tech, Cisco, Web, It, Vc, Artificial Intelligence, Software, Fundraising

Seattle’s Outreach Joins Unicorn Ranks With $114M Funding Round

Another tech “unicorn”—privately controlled startups valued at $1 billion or more—has been minted following sales software company Outreach’s latest venture funding round, a $114 million deal.Seattle-based Outreach develops customer relationship management tools designed to improve communication between salespeople and their prospective clients. Launched in 2013, the startup says its most recent round of financing values Outreach at $1.1 billion and brings its total funding haul to $239 million...
Tags: Deals, Startups, Uber, Pinterest, Microsoft, Sales, Trends, Tech, IPOs, Outreach, Vc, Seattle, Unicorns, Drift, Dfj Growth, Meritech Capital partners

Founders’ Co-op Raises $25M to Back More Pacific Northwest Startups

Founders’ Co-op, a Seattle-based venture capital firm that has backed nearly 100 startups since its launch 11 years ago, has raised a new, $25 million fund to continue making investments.According to a document filed with federal securities regulators, it’s the fourth fund Founders’ Co-op has raised, and the money came from 99 investors.In an email message, Founders’ Co-op managing partner Chis DeVore confirmed it recently raised money for a new investment fund. Asked about the firm’s plans wit...
Tags: Amazon, Deals, Startups, Verizon, Trends, Outreach, Vc, Shipping, Ai, Baidu, Logistics, Seattle, Cleantech, TechStars, Verizon Communications, CRM

Show Me The Money: Seattle’s Showdigs Gets $3M for Real Estate Tools

Showdigs, a Seattle-based startup developing software to help prospective leasers schedule tours of apartments property managers have for rent, says it has raised $3 million in new funding to support its continued growth.A local investor, Bellevue, WA-based Trilogy Equity Partners, led the seed funding round, Showdigs says in a news release.Showdigs’ location-based tools allow apartment hunters to book showings on their own, which it says can lead to time savings for people who work in leasing ...
Tags: Deals, Startups, Real Estate, Trends, Tech, Vc, Software, Seattle, Zillow, On-demand Economy, Gig Economy, Redfin, Real Estate Agents, National blog main, Seattle blog main, Seattle top stories

Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon

The gene therapy boom continued this morning with yet another acquisition.Contract drug manufacturer Catalent (NYSE: CTLT), of Somerset, NJ, has agreed to buy Paragon Bioservices for $1.2 billion, grabbing hold of a privately held developer of the viral “vectors” that gene therapy companies use to deliver their treatments.In a gene therapy procedure, these vectors—engineered viruses—are filled with genetic blueprints and infused into a patient’s body. Those viruses then deliver their instructio...
Tags: Deals, New York, Trends, Fda, Novartis, Life Sciences, Roche, Thermo Fisher Scientific, Biogen, Gene Therapy, National blog main, New York blog main, New York top stories, Spark Therapeutics, Johnson & Johnson, AveXis

Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs

When a much-watched tech company such as Lyft, Uber, or Pinterest files for an initial public stock offering, people eagerly scour the sudden trove of information that such a private business must finally disclose when it begins to offer shares to the general public, rather than only to sophisticated inside investors such as venture capital firms.For newly public company Lyft, (NASDAQ: LYFT) though, the IPO disclosure requirements were significantly lower than they would usually be for business...
Tags: Deals, Startups, Transportation, Mobile, Lyft, Uber, Hardware, Pinterest, Internet, Entrepreneurship, Ipo, Funding, San Francisco, Trends, Tech, Financial Crisis

Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout

The early opposition has turned out to be just noise. Shareholders of Bristol-Myers Squibb today approved the pharma giant’s planned buyout of Celgene, paving the way for a deal that will create one of the largest biopharma organizations in the world, and send ripples throughout the sector. (NYSE: BMY) said Friday that more than 75 percent of its shareholders voted to approve the deal at a meeting on Friday. Some 98 percent (NASDAQ: CELG) of Celgene’s stockholders supported the deal, the compa...
Tags: Deals, New York, Trends, Merck, M&a, Life Sciences, Nyse, Celgene, Bristol-myers Squibb, National blog main, New York blog main, New York top stories, Seattle blog main, Seattle top stories, Boston blog main, National top stories

Boston Tech Watch: Tufin, Facebook, RightHand, Diameter & Jebbit

A cybersecurity IPO could raise up to $124 million for an Israeli-based company with its US headquarters in Boston. Facebook’s Boston office wants to map the world’s population in high def, starting with Africa. More venture cash is flowing into Bay State startups. Read all this and much more in this week’s roundup of local tech news.—Tufin Software Technologies, a cybersecurity company based in Israel with its US headquarters in Boston, went public this week and is listed on the New York Stock...
Tags: Deals, Startups, Facebook, Boston, Softbank, Israel, US, Trends, Tech, Connecticut, Weather Forecast, New York Stock Exchange, Eric Schmidt, Video Game, Affectiva, Healthtech

WI Watchlist: DotCom Therapy, Nordic, UWM, Epic

It’s time to catch up on recent happenings in Wisconsin’s innovation community:—Madison-based telemedicine startup DotCom Therapy named Sanaz Cordes as its chief executive and said it raised an undisclosed amount of funding from HealthX Ventures, a local venture firm that backs healthtech companies. Cordes is a physician and former chief operations officer of another Madison-based healthtech startup, Healthfinch.DotCom Therapy develops software to connect patients with remotely located therapis...
Tags: Deals, Startups, Mobile, Apps, Education, Trends, Tech, Web, Development, It, Vc, Software, Healthcare, Coding, Wisconsin, Ey

AskBio Reels In $235M to Advance Gene Therapy Clinical Trials

Asklepios BioPharmaceutical (AskBio) has raised $235 million in financing to support its research and development of gene therapies for rare, genetic disorders.The funding came from TPG Capital and Vida Ventures, which together invested $225 million and gained a minority stake in the Research Triangle Park, NC, company. Concurrent with that investment, AskBio’s founders and board members invested $10 million. The AskBio funding is the latest in a flurry of gene therapy investments that have swe...
Tags: Deals, Drugs, Trends, Investing, Venture Capital, Fda, Pfizer, Parkinson's Disease, Biotech, Tpg Capital, Life Sciences, Clinical Trials, Roche, Thermo Fisher Scientific, Biogen, University of North Carolina at Chapel Hill

Apana Gulps Down $11M to Help Costco, Other Clients Track Water Use

Apana, which develops systems of sensor-equipped devices and complementary software to help facilities monitor their water use, announced Tuesday it has raised $11 million to fuel its continued growth.Grocery stores, hotels, bars, and restaurants are among those who use Apana’s products and services, which the Bellingham, WA-based company says can help these organizations save money by reducing their water consumption.Apana’s customers include Issaquah, WA-based Costco (NASDAQ: COST), the MGM G...
Tags: Deals, Startups, Internet Of Things, California, Trends, Water, Vc, Iot, Smart Home, Smart Meters, Seattle, Costco, Smart Homes, MGM Grand, Bellingham WA, National blog main

Sobriety Pays: DynamiCare Gamifies Staying Clean for Recovering Addicts

Eric Gastfriend was looking for his next tech startup idea after leaving his video game startup Happy Cloud and finishing an MBA at Harvard Business School when the inspiration came from a source close to home.A relative was entering rehab for alcohol abuse for the second time, he says. Gastfriend asked his father—David Gastfriend, director of addiction research at Massachusetts General Hospital—why treatments sometimes don’t seem to stick and people with substance disorders relapse.“My dad sai...
Tags: Deals, Boston, Alcohol, Trends, Tech, App, Substance Abuse, Addiction, Health Tech, VCs, Massachusetts General Hospital, Akili Interactive, Harvard Business School, National blog main, Boston blog main, National top stories

VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less

If you’ve been following venture capital trends, what you expected to happen in the first quarter of 2019 did: More money is being invested in fewer deals, and women founders still are getting less of it than men.Venture firms sent $32.6 billion into startups nationally during the first three months of 2019, the second largest amount for any quarter since at least 2006, according to data released overnight by PitchBook and the National Venture Capital Association. But that large sum came from o...
Tags: Deals, Startups, Lyft, Uber, Hardware, Entrepreneurship, Softbank, Funding, Women, Trends, Tech, Vc, Software, Physics, Pwc, Venture Capital

Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases

Alnylam and Regeneron Pharmaceuticals are announcing a wide-ranging alliance this morning to co-develop treatments for eye and neurological diseases using RNA interference, a method of drugmaking that has recently come of age after years of ups and downs.Regeneron (NASDAQ: REGN), of Tarrytown, NY, will pay Alnylam (NASDAQ: ALNY) $400 million in cash up front and buy $400 million in Alnylam stock—4.44 million shares at $90.01 apiece—to kickstart the deal. Cambridge, MA-based Alnylam could get an...
Tags: Deals, Boston, Trends, Life Sciences, Clinical Trials, Alexion Pharmaceuticals, Regeneron, Cambridge MA, Regeneron Pharmaceuticals, Alnylam, Alnylam Pharmaceuticals, National blog main, New York blog main, New York top stories, Boston blog main, National top stories

RiskLens Raises $20M for Software That Quantifies Cyber Risk

RiskLens, a developer of software for assessing, communicating, and managing cyber risk, announced Monday it has raised more than $20 million from investors.Spokane, WA-based RiskLens says it plans to use some of the proceeds from the Series B funding round to expand its sales, marketing, engineering, and professional services teams. They’ll work to try to capture a larger portion of the global market for cyber security products and services, which is expected to be worth more than $180 billion...
Tags: Deals, Security, Startups, Sutter Health, Trends, Insurance, Tech, Cybersecurity, Vc, Hacks, Seattle, Maersk, Fedex, Doordash, Data Breaches, MassMutual

Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More

Scott Gottlieb’s last day as FDA commissioner is today. His resignation announcement last month surprised some, given the earlier denials about leaving. But after two years of commuting between Connecticut, where his family remained, and the FDA’s Maryland headquarters, he decided to step down from the agency.What will Gottlieb’s legacy be? His efforts to curb teen vaping comes to mind. Or maybe it’s regulation. While Gottlieb remained mindful of the FDA’s oversight role, he also tried to strea...
Tags: Deals, Startups, Maryland, Breast Cancer, Trends, Investing, Lung Cancer, Connecticut, Cigna, Venture Capital, Fda, National, Novartis, Pfizer, Biotech, Insulin

NGM Bio’s IPO Raises $107M as NASH Drug Continues Clinical Testing

So far this year, NGM Biopharmaceuticals has licensed a drug to Merck, extended a research agreement with that partner, and laid the groundwork to continue mid-stage testing of its wholly-owned lead compound. Now it can add a $107 million IPO to the list.Late Wednesday, NGM sold appoximately 6.7 million shares for $16 apiece, the high end of the price range the South San Francisco company had planned. Those shares are expected to begin trading on the Nasdaq exchange Thursday under the stock sym...
Tags: Deals, Drugs, Ipo, Cancer, San Francisco, Trends, Investing, Merck, Diabetes, Venture Capital, Fda, Type 2 Diabetes, Biotech, Nasdaq, Life Sciences, Clinical Trials

Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease

One problem with drugs for muscular disorders is that not enough medicine reaches the muscle, says Romesh Subramanian, CEO of Dyne Therapeutics. Subramanian’s startup has developed a way to deliver drugs to all muscle types, and it is emerging from stealth with $50 million in funding to advance its compounds toward human testing.Dyne was founded last year by Atlas Venture, which seeded and incubated the Cambridge, MA-based biotech. Atlas also invested in Dyne’s Series A funding announced Wednes...
Tags: Deals, Startups, Drugs, Boston, Trends, Investing, Atlas, Netherlands, Venture Capital, Cambridge, Fda, Biotech, Life Sciences, Clinical Trials, Biogen, Alexion Pharmaceuticals

Lear to Acquire Seattle Connected Vehicle Tech Firm Xevo For $320M

Lear Corp., a Southfield, MI-based manufacturer of car seats, automotive electrical systems, and other products, announced Tuesday it has agreed to acquire Xevo, a Seattle-based developer of connected vehicle software, for $320 million.Lear (NYSE: LEA) has been in business for over a century, and says its products are used by nearly every major automaker. The company’s sales were $21.1 billion last year. Lear says it has about 169,000 employees across 257 locations in 39 countries.Xevo, in turn...
Tags: Deals, Startups, Cars, Trends, Tech, Software, M&a, Autos, Lea, Seattle, Connected Vehicles, Acquisitions, Southfield, Lear, Lear Corp, John Absmeier

Seattle Venture Capital Watch: Crelate, Cyemptive, Blue Canoe & More

Businesses developing software to assist recruiters, corporate IT departments, and people learning to speak English are among the Seattle-area companies that have in recent weeks raised new funding from investors. Let’s catch up on some of the Emerald City Deals action.—Crelate Talent, which is developing recruiting software used by staffing agencies, executive search firms, and other organizations, raised more than $5.3 million in equity funding from 22 investors, according to an SEC filing. O...
Tags: Amazon, Deals, Startups, Apps, Nsa, Trends, Tech, Recruiting, It, HR, Cybersecurity, Vc, Software, Language, SEC, Seattle

EzCater Celebrates “Unicorn” Status After $150M Funding Round

Stefania Mallett was sitting at her kitchen table when she wrapped up the details behind her catering technology startup ezCater’s latest funding round, a $150 million investment.Mallett shared the details to her husband before the size of the occasion sank in.“I’m busy, already onto the next thing. He said, ‘Wait, that is a big number.’ I looked at him and it dawned on me: ‘That is a big number,'” Mallett recalled.That figure is the software company’s latest valuation by its investors: $1.25 b...
Tags: Deals, Boston, Restaurants, Singapore, CA, Trends, Tech, Vc, Paris, Vancouver, Tiger Global, Denver, Lightspeed Venture Partners, Iconiq Capital, Unicorn, Insight Venture Partners

show more filters
February - 2019
March - 2019
April - 2019